Latest Intercept Pharmaceuticals Inc. Stories
NEW YORK, Feb. 24, 2014 /PRNewswire/ -- Bronstein, Gewirtz & Grossman, LLC announces that a securities class action has been filed in the United States District Court for the Southern District of New York on behalf of those who purchased shares of Intercept Pharmaceuticals, Inc. ("Intercept" or the "Company") (NasdaqGS: ICPT ), during the period between January 9, 2014 and January 10, 2014, inclusive (the "Class Period"). The complaint charges Intercept and certain of its...
- An evil spirit; a devil.
- A nightmare.